BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2300478
,
BRAF
,
Angiogenesis
,
Ischemia
,
Intestine
,
Amniocentesis
,
Lipitor
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
most potent inhibitors
Summary
General Info
Curated Studies
Most Correlated Studies
Skin BJ fibroblasts post sodium arsenite treatment
T-cell acute lymphoblastic leukemia Jurkat cells treated with trichostatin A
Clival chordoma UM-Chor1 cells treated with THZ1 or actinomycin D
Livers of rats treated with dithiolethione analogs D3T, OLT, or TBD
Breast cancer MDA-MB-468, MDA-MB-231, and MDA-MB-157 cells with thalidomide, BETi-211, or BETd-246
Explore Curated Studies Results
Literature
Most Relevant Literature
Discovery of aromatic 2-(3-(methylcarbamoyl) guanidino)-N-aylacetamides as highly potent chitinase i…
New bysspectin A derivatives as potent inhibitors of human carboxylesterase 2A.
Structure-Activity Relationship Studies on Cell-Potent Nicotinamide N-Methyltransferase Bisubstrate …
Thioquinoline derivatives conjugated to thiosemicarbazide as potent tyrosinase inhibitors with anti-…
Biochemical Screening of Potent Zika Virus Protease Inhibitors.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Efficacy and Safety of Dupilumab Chronic Hands Eczema Refractory to Highly Potent Topical Corticoste…
POTENT - Tepotinib in Combination With Pembrolizumab in NSCLC
Identification of Biomarkers of Janus Kinase Inhibitor Therapy in Patients With Ulcerative Colitis
Akt Inhibitor MK2206 in Treating Patients With Advanced Breast Cancer
Co-Administering Testosterone With PDE5 Inhibitors in ED Patients Non Responders to PDE5 Inhibitors …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ